Gracell Biotechnologies Inc. (NASDAQ:GRCL) Q3 2022 Results Earnings Conference Call November 14, 2022 8:00 AM ET

Company Participants

Kevin Yili Xie - Chief Financial Officer

William Wei Cao - Founder, Chairman, and Chief Executive Officer

Wendy Li - Chief Medical Officer

Conference Call Participants

Carly Kenselaar - Citigroup

Dev Prasad - Jefferies

Joseph Catanzaro - Piper Sandler

Justin Zelin - BTIG

Suowei Wu - Cantor Fitzgerald

James Shin - Wells Fargo

Operator

Ladies and gentlemen, thank you for standing by. Welcome to Gracell Biotechnologies Third Quarter 2022 Conference Call. At this time, all participants are in a listen-only mode. After the opening remarks, we will open the call for your questions. Instructions for queuing up will be given at that time.

I will now turn the conference call over to Dr. Kevin Xie, CFO. Please go ahead.

Kevin Yili Xie

Good morning. And welcome to Gracell's third quarter 2022 corporate update conference call and webcast. With me today are Gracell's Founder and Chief Executive Officer, Dr. William Cao, and our Chief Medical Officer, Dr. Wendy Li.

We're excited to discuss the progress of our innovative technologies and the rich clinical pipeline of CAR-T therapies on today's call. We also look forward to sharing with you our recent business developments and upcoming objectives for the remainder of 2022. After our formal remarks, we'll conduct a question-and-answer session.

This morning, Gracell issued a press release announcing unaudited financial results for the quarter ended September 30, 2022. We encourage everyone to read this press release. And I would like to remind you that this call is being recorded for replay.

Please note that, for certain information discussed on the call today, including financial data, clinical data and future plans of our programs, resource management will be making forward-looking statements. Actual results could differ materially from those stated or implied by those forward-looking statements as a result of various important factors. And please refer to the Risk Factors section of our latest 20-F filings with the SEC for a full disclosure of these risks and factors.

The conference call contains time sensitive information that is accurate only as of the date of this live broadcast, November 14, 2022. Gracell undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this conference call, except as may be required by security laws.

I will now turn the call over to Gracell's CEO, Dr. William Cao. William?